Charles River Laboratories International Inc (NYSE:CRL) currently has a daily average trading volume of 865.51K but it saw 1524859 shares traded in last market. With a market cap of 8.59B USD, the company’s current market price of $167.96 came rising about 0.51 while comparing to the previous closing price of $167.10. In past 52 weeks, the stock remained buoying in the range of price level as high as $275.00 and as low as $150.79.
Taking a look at 20-day trading activity of Charles River Laboratories International Inc (CRL) gives us an average price of $161.84, while its current price level is -38.92% below from 52-week high level whereas it is 11.39% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $173.14 while that of 200 days or SMA-200 reads an average of $197.03. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.44% during that period while stretching the period over a month that decreases to 3.09%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 52.76 which implies that the stock is in neutral territory.
UBS downgraded its recommendation for the stock as a “Neutral” from “Buy” on January 17, 2025 while assigning a price target range of $250-$185. CLSA also issued its recommendations for the stock as it downgraded the price target for the stock is $164.
Over the week, CRL’s stock price is moving 1.79% up while it is 1.28% when we observe its performance for the past one month. Year-to-date it is -9.01% down and over the past year, the stock is showing a downside performance of -32.19%.
Currently, Charles River Laboratories International Inc’s total number of outstanding shares is 51.14M. Company’s return on investment (ROI) stands at 0.26% and return on equity (ROE) at 0.45%. It has a price to earnings ratio (P/E ratio) of 654.81 while having a 16.19 of forward P/E ratio. Stock’s beta reads 1.45. Stock has a price to book (P/B) ratio of 2.48 while price to sale or P/S ratio amounts to 2.12. Its return on asset (ROA) is 0.20% on average.
